Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.

Conjugation Chemistry with Highly Potent Compounds

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Global outbreaks energize vaccine R&D and drive production modernization.

Vaccine Development Faces  Urgency and Challenges

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Pharmaceutical Technology spoke with FDA to get the agency’s insights on how the industry can ensure quality in solid and semi-solid dosage products.

FDA Insights on Quality in Solid Dosage Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.

Biopharmaceutical Outsourcing Continues to Grow

Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.

Biotech Manufacturers Explore Global Access and Supply Chain Hurdles

Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.

Novo Nordisk Builds Manufacturing Facility in North Carolina

A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.

Bristol-Myers Squibb Collaborates with Bioprocessing Institute in Ireland

Collaboration will provide for unified development and manufacture of antibody drug conjugates.

CMC Biologics and IDT Biologika Collaborate on ADC Manufacturing

The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.

Pfizer Joins the Human Vaccines Project

During a clinical trial of 48 participants, 100% of those that received the TV003 vaccine were protected from infection.